The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Buscopan Ampoules 20 mg/ml Solution for Injection

20 milligram(s)/millilitre Solution for injection

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/181/001

Main Information

Trade NameBuscopan Ampoules 20 mg/ml Solution for Injection
Active SubstancesHyoscine butylbromide
Strength20 milligram(s)/millilitre
Dosage FormSolution for injection
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/181/001

Group Information

ATC CodeA03BB Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
A03BB01 butylscopolamine

Status

Authorised/WithdrawnAuthorised
Licence Issued01/04/1979
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back